Underpinned by technology advancements, modern automated systems are already adept of a broad set of functions that have been previously carried out by manual, tedious labour. Instrumentation keeps on developing and is poised to perform tasks that were not even imaginable just some years ago. Initially used mostly by the big pharma and biotech companies, lab automation technology has evolved fast to satisfy a larger group of clinical experts in the life sciences field. Besides producing automation for particular customer needs, automation companies also make easy-to-use, smaller systems that are far more accessible to clinical experts to comply with their needs.
The lab automation market value is projected to surpass the USD 16 billion mark by end-2022. The major growth drivers include innovative instruments and reagents, improved efficiency and decreases in costs, and latest developments in lab instrumentation, among others. However, the absence of compatibility between systems in a laboratory and challenges in contemporary technologies are threatening the sector’s expansion.
The USA takes the lead in the clinical lab automation market, with Europe and Japan, respectively, following after. Application-wise, Work Station and LIMS grab the lion’s share of the market. Work station is anticipated to lead the market in 2022, with LIMS coming second. Other applications comprise sample transport system and specimen handling system, which are likely to hold the third and fourth positions in the overall clinical lab automation marketplace.
New research study “Lab Automation Market – Global Industry Analysis and Opportunities Assessment 2012 – 2022” prepared DPI Research offers a comprehensive examination of the market, providing deep insights, true facts, historical figures and trustworthy data and forecasts. The report provides a deep analysis and important information on the sector with respect to such categories as market segments, regions, product types and key deals in the lab automation universe. The study provides sizing and 6-year forecasts for the overall market and its segments. It also presents forecasts for the main regional and country markets, by value, – the USA, Europe, Japan, the so-termed BRIC nations and RoW.